市場調査レポート
商品コード
1245707

ジストニア治療薬の世界市場規模、シェア、産業動向分析レポート:流通チャネル別、投与経路別、タイプ別(GABA作動薬、ドーパミン作動薬、抗痙攣薬)、地域別展望と予測、2022年~2028年

Global Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type (GABAergic Agents, Dopaminergic Agents, Anticonvulsants Drugs), By Regional Outlook and Forecast, 2022 - 2028

出版日: | 発行: KBV Research | ページ情報: 英文 200 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
ジストニア治療薬の世界市場規模、シェア、産業動向分析レポート:流通チャネル別、投与経路別、タイプ別(GABA作動薬、ドーパミン作動薬、抗痙攣薬)、地域別展望と予測、2022年~2028年
出版日: 2023年02月28日
発行: KBV Research
ページ情報: 英文 200 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ジストニア治療薬の世界市場規模は、2028年には11億米ドルに達し、予測期間中にCAGR5.4%の市場成長率で上昇すると予測されています。

ジストニアは、運動協調を司る深部脳領域である基底核の機能障害によって引き起こされます。これらの脳領域は、動きの速さと流動性を調節し、望ましくない動きを回避します。ジストニア患者は、不随意的なねじれ、繰り返される運動、または異常な姿勢や位置を示すことがあります。これには、腕、脚、体幹、顔、声帯が含まれます。

ジストニアの起源は不明ですが、多くの脳領域やその結合に変化が生じている可能性があります。ジストニアは、遺伝性、後天性、特発性(原因不明)のいずれでもあり得ます。遺伝性のものは、遺伝的に伝わる病気です。後天性の場合、ジストニアは脳の損傷や変性(例えば、脳損傷や脳卒中の後)、または薬物への曝露によって引き起こされます。特発性ジストニアでは、原因はわかっておらず、脳の解剖学的損傷や変性もないです。

COVID-19影響度分析

COVID-19の発生は、ヘルスケア分野の業務に影響を与えています。ヘルスケアの様々なサブドメインを含むいくつかの産業が、COVID-19のために一時的な閉鎖を余儀なくされています。2020年、COVID-19に端を発した経済減速により、ジストニア治療薬の市場は減少しました。さらに、COVID-19はヘルスケアなどの事業におけるサプライチェーンに影響を及ぼし、市場の成長をさらに抑制しました。しかし、パンデミックの緩和により、ビジネスやサプライチェーンが正常に戻りつつあり、市場の回復を助けると予想されます。

市場成長要因

医薬品研究開発の強化

連邦政府は、処方薬の需要を高めるプログラム、新薬の供給に影響を与える政策(基礎研究への支出や臨床試験で実証されるべき内容に関する規制など)、需要と供給の両方に影響を与える政策(ワクチンの推奨など)を通じて、民間研究開発費に影響を及ぼします。製薬業界における世界の研究開発の進展は、ジストニア治療薬の有効性とその利用を促進し、市場の成長を後押しすると期待されます。

神経系疾患の有病率の上昇

世界保健機関(WHO)の新しい調査によると、神経疾患は世界で10億人もの人々に影響を及ぼしています。神経疾患は、年齢、性別、教育レベル、お金に関係なく、すべての国の個人に影響を与えます。年間約680万人が神経疾患のために亡くなっています。神経疾患の患者さんやその家族、医療従事者にとって、適切なケアへのアクセスは困難です。プライマリーヘルスケアは、多くの人々にとって唯一の医療へのアクセスです。非常に効果的で安価な薬があるにもかかわらず、多くの神経疾患患者が未治療のままです。神経疾患を持つ人々により良い治療を提供するために、医療システムを強化する必要があります。

市場抑制要因

必要な医療を受けられない国民が圧倒的に多い

世界銀行と世界保健機関の新しい調査によると、少なくとも半数の国民が重要な医療を受けられないでいます。そして毎年、多くの世帯が医療費を支払わなければならないために、貧困に追い込まれています。現在、8億人の人々が、自分自身や病気の子供、あるいは他の家族のために、家計の少なくとも10パーセントを健康関連費用に費やしています。これらの費用は、約1億人が1日1.90ドル以下で生活しなければならない極貧状態に追い込まれるのに十分です。

タイプ別展望

ジストニア治療薬市場は、タイプ別に、抗けいれん薬、GABA作動性薬剤、ドパミン作動性薬剤、その他に分類されます。GABA作動性薬剤セグメントは、2021年に最大収益シェアでジストニア治療薬市場を独占しました。この成長は、ジストニア、特に頸部ジストニアの治療におけるその利点に起因しています。また、ジストニアの治療に有効で強力なGABA作動性薬剤医薬品の発見と、ヘルスケア専門家によるより包括的な処方が、予測期間における同分野の拡大を後押ししています。

投与経路の展望

投与経路に基づき、ジストニア治療薬市場は経口剤と注射剤に分けられます。注射剤セグメントは、2021年のジストニア治療薬市場でかなりの収益シェアを調達しました。これは、非経口投与の技術革新が進み、ボツリヌス注射の研究開発が活発化しているためです。薬物、特に水溶液の吸収は迅速かつ均一です。経口や皮下投与に比べ、効果の開始が早いです。筋肉内注射は、薬剤の初回通過代謝をバイパスします。

流通チャネルの展望

流通チャネル別に、ジストニア治療薬市場は、病院薬局、オンラインプロバイダー、ドラッグストア&小売薬局に分類されます。ドラッグストア&小売薬局セグメントは、2021年のジストニア治療薬市場において最大の収益シェアを示しました。これは、その広範な流通網のチェーンと、消費者に医薬品を提供するための最も古く便利なチャネルであることに起因しています。小売薬剤師は、医薬品の準備と調剤を行い、消費者に医薬品の適切な使用について相談し、潜在的な薬物相互作用について知らせます。また、市販薬や一般的な健康に関するアドバイスも行っています。

地域の展望

地域別に、ジストニア治療薬市場を北米、欧州、アジア太平洋、LAMEAで分析しています。2021年のジストニア治療薬市場では、北米地域が最も高い収益シェアを獲得しています。これは、ジストニアの発生が増加していることと、ジストニアを引き起こす他の神経疾患の有病率が人口比で上昇していることが理由です。また、同地域では、整備されたヘルスケアインフラの存在、高い購買力、ジストニアの診断・治療の増加などが挙げられます。満たされていないヘルスケア需要の多さ、良好な規制環境の存在が、市場の拡大を後押しすると予測されます。

目次

第1章 市場の範囲と調査手法

  • 市場の定義
  • 目的
  • 市場の範囲
  • セグメンテーション
    • ジストニア治療薬の世界市場、流通チャネル別
    • ジストニア治療薬の世界市場、投与経路別
    • ジストニア治療薬の世界市場:タイプ別
    • ジストニア治療薬の世界市場、地域別
  • 調査手法

第2章 市場の概要

  • イントロダクションです
    • 概要
      • 市場の構成とシナリオ
  • 市場に影響を与える主要因
    • 市場促進要因
    • 市場抑制要因

第3章 ジストニア治療薬の世界市場:流通チャネル別

  • ドラッグストア・小売薬局の世界市場:地域別
  • 病院内薬局の世界市場:地域別
  • オンラインプロバイダーの世界市場:地域別

第4章 ジストニア治療薬の世界市場:投与経路別

  • 経口剤の世界市場:地域別
  • 注射剤の世界市場:地域別

第5章 ジストニア治療薬の世界市場:タイプ別

  • GABA作動性薬剤の世界市場:地域別
  • ドパミン作動性薬剤の世界市場:地域別
  • 抗けいれん薬の世界市場:地域別
  • 地域別の世界のその他市場

第6章 ジストニア治療薬の世界市場:地域別市場

  • 北米
    • 北米のジストニア治療薬市場国別推移
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州のジストニア治療薬市場:国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域のジストニア治療薬市場:国別一覧
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAのジストニア治療薬の国別市場
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • LAMEAの残りの地域

第7章 企業プロファイル

  • Pfizer, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ipsen Pharma Biotech SAS
  • Hameln Pharma Gmbh(Siegfried Group, LLP)
  • Amneal Pharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Wellona Pharma
図表

LIST OF TABLES

  • TABLE 1 Global Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 2 Global Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 3 Global Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Drug Stores & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Drug Stores & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Online Providers Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Online Providers Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 12 Global Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 13 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Injectable Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Injectable Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 18 Global Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 19 Global GABAergic Agents Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global GABAergic Agents Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Dopaminergic Agents Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Dopaminergic Agents Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Anticonvulsants Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Anticonvulsants Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Dystonia Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Dystonia Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 30 North America Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 31 North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 32 North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 40 North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 41 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 46 North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 47 North America GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 58 US Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 59 US Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 60 US Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 61 US Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 62 US Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 63 US Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 64 US Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Canada Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 66 Canada Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 67 Canada Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 68 Canada Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 69 Canada Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 70 Canada Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 71 Canada Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 72 Canada Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 73 Mexico Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 74 Mexico Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 75 Mexico Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 Mexico Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 Mexico Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 78 Mexico Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 79 Mexico Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 80 Mexico Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 89 Europe Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 92 Europe Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 93 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 100 Europe Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 101 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 106 Europe Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 107 Europe GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Germany Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 118 Germany Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 119 Germany Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 120 Germany Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 121 Germany Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 122 Germany Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 123 Germany Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Germany Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 125 UK Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 126 UK Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 127 UK Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 128 UK Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 129 UK Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 130 UK Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 131 UK Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 132 UK Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 133 France Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 134 France Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 135 France Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 France Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 France Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 138 France Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 139 France Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 140 France Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 141 Russia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 142 Russia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 143 Russia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 Russia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 Russia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 146 Russia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 147 Russia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 148 Russia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 149 Spain Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 150 Spain Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 151 Spain Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 Spain Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Spain Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 154 Spain Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 155 Spain Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 156 Spain Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 157 Italy Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 158 Italy Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 159 Italy Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Italy Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Italy Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 162 Italy Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 163 Italy Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 164 Italy Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 167 Rest of Europe Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Rest of Europe Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Rest of Europe Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 170 Rest of Europe Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 201 China Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 202 China Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 203 China Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 204 China Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 205 China Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 206 China Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 207 China Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 208 China Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 209 Japan Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 210 Japan Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 211 Japan Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 212 Japan Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 213 Japan Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 214 Japan Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 215 Japan Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 216 Japan Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 217 India Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 218 India Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 219 India Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 India Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 India Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 222 India Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 223 India Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 224 India Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 225 South Korea Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 226 South Korea Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 227 South Korea Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 228 South Korea Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 229 South Korea Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 230 South Korea Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 231 South Korea Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 232 South Korea Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 233 Singapore Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 234 Singapore Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 235 Singapore Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 236 Singapore Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 237 Singapore Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 238 Singapore Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 239 Singapore Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 240 Singapore Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 241 Malaysia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 242 Malaysia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 243 Malaysia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 244 Malaysia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 249 Rest of Asia Pacific Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 250 Rest of Asia Pacific Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 275 LAMEA GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 276 LAMEA GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Brazil Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 286 Brazil Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 287 Brazil Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 288 Brazil Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 289 Brazil Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 290 Brazil Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 291 Brazil Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 292 Brazil Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 293 Argentina Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 294 Argentina Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 295 Argentina Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 296 Argentina Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 297 Argentina Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 298 Argentina Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 299 Argentina Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 300 Argentina Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 301 UAE Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 302 UAE Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 303 UAE Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 304 UAE Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 305 UAE Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 306 UAE Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 307 UAE Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 308 UAE Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 309 Saudi Arabia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 310 Saudi Arabia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 317 South Africa Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 320 South Africa Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 321 South Africa Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 322 South Africa Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 323 South Africa Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 324 South Africa Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 329 Nigeria Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 330 Nigeria Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 331 Nigeria Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 332 Nigeria Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 335 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 336 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 337 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 338 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 339 Rest of LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 340 Rest of LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 341 Key Information - Pfizer, Inc.
  • TABLE 342 Key Information - Novartis AG
  • TABLE 343 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 344 Key information - AbbVie, Inc.
  • TABLE 345 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 346 Key Information - Ipsen Pharma Biotech SAS
  • TABLE 347 Key Information - Hameln Pharma Gmbh
  • TABLE 348 Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 349 Key information - Merz Pharma GmbH & Co. KGaA
  • TABLE 350 Key Information - Wellona Pharma

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Dystonia Drugs Market Share by Distribution Channel, 2021
  • FIG 3 Global Dystonia Drugs Market Share by Distribution Channel, 2028
  • FIG 4 Global Dystonia Drugs Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Dystonia Drugs Market Share by Route of Administration, 2021
  • FIG 6 Global Dystonia Drugs Market Share by Route of Administration, 2028
  • FIG 7 Global Dystonia Drugs Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 8 Global Dystonia Drugs Market Share by Type, 2021
  • FIG 9 Global Dystonia Drugs Market Share by Type, 2028
  • FIG 10 Global Dystonia Drugs Market by Type, 2018 - 2028, USD Million
  • FIG 11 Global Dystonia Drugs Market Share by Region, 2021
  • FIG 12 Global Dystonia Drugs Market Share by Region, 2028
  • FIG 13 Global Dystonia Drugs Market by Region, 2018 - 2028, USD Million
目次

The Global Dystonia Drugs Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.

Dystonia is a movement disease characterized by involuntary muscle contractions that lead to repetitive sluggish motions or aberrant postures. This muscle contraction results in aberrant muscle motions and body positions. Various types of dystonia can affect a single muscle, a group of muscles, or all of the body's muscles. It is caused by illnesses such as brain injury at or around birth, certain infections, brain trauma, and other vascular abnormalities, including stroke, arteriovenous, and others.

Patients may experience unpleasant movements or tremors as a result. There is no specific treatment for dystonia. However, its symptoms can be alleviated with various drugs. Uncontrollable muscular contractions characterize the neurological movement disorder dystonia. It is a condition that has no age, ethnic, or racial borders; it can afflict children and people of all races and ethnicities from infancy to old age.

Dystonia is caused by faulty basal ganglia functioning, a deep brain region that controls movement coordination. These brain regions regulate the speed and fluidity of movement and avoid undesired motions. Dystonic patients may exhibit involuntary twisting, repeated motions, or aberrant postures and positions. This includes the arms, legs, trunk, face, and vocal cords.

The origin of dystonia is unknown, but it may entail alterations in many brain regions or their connectivity. Dystonia may be genetic, acquired, or idiopathic in origin (no known cause). Inherited illnesses are genetically transmitted. In acquired forms, dystonia is caused by brain damage or degeneration (e.g., following a brain injury or stroke) or drug exposure. There is no known cause and no anatomical injury or degeneration of the brain in idiopathic dystonia.

COVID-19 Impact Analysis

The outbreak of COVID-19 has affected operations in the healthcare sector. Several industries, including various sub-domains of health care, have been forced to close temporarily due to COVID-19. In 2020, the market for dystonia drugs declined due to the economic slowdown triggered by COVID-19. Furthermore, COVID-19 impacted the supply chain in businesses such as healthcare, further restricting the market growth. However, with ease in the pandemic, businesses and supply chains are returning to normal, which is expected to aid the market in recovery.

Market Growth Factors

Enhancement of pharmaceutical research and development

The federal government influences private spending on research and development through programs that increase the demand for prescription drugs, through policies (like spending for basic research and regulations on what must be demonstrated in clinical trials) that affect the supply of new medicines, and through policies (like vaccine recommendations) that affect both supply and demand. The growing R&D in the pharmaceutical industry globally is expected to enhance the effectiveness of dystonia drugs and their utilization, thereby boosting the market growth.

Rise in the prevalence of neurological illnesses

According to new research from the World Health Organization (WHO), neurological illnesses impact up to one billion people globally. Neurological diseases impact individuals in all nations, regardless of age, gender, level of education, or money. Around 6.8 million people die annually due to neurological illnesses. Access to adequate care is challenging for many individuals with neurological illnesses, their families, and care providers. Primary health care is the only access to medical care for many individuals. Despite the availability of highly effective, inexpensive medications, many people with neurological disorders remain untreated. Health systems must be fortified to provide better treatment for individuals with neurological illnesses.

Market Restraining Factors

Vast amount of the population unable to receive necessary medical care.

According to new research from the World Bank and the World Health Organization, at least half of the population lacks access to crucial health care. And each year, many households are forced into poverty because they must pay for their health care. Nowadays, 800 million people spend at least 10 percent of their household budgets on health-related expenses for themselves, a sick kid, or another family member. These costs are sufficient to force about 100 million people into extreme poverty, requiring them to live on $1.90 or less per day.

Type Outlook

Based on type, the dystonia drugs market is segmented into anticonvulsants drugs, GABAergic agents, dopaminergic agents and others. The GABAergic agents segment dominated the dystonia drugs market with maximum revenue share in 2021. The growth is attributed to its benefits in treating dystonia, particularly cervical dystonia. In addition, the discovery of highly effective and potent GABAergic agent pharmaceuticals for treating dystonia, combined with its more comprehensive prescription by healthcare experts, is fueling the segment's expansion in the forecasted period.

Route of Administration Outlook

On the basis of route of administration, the dystonia drugs market is divided into oral and injectable. The injectable segment procured a substantial revenue share in the dystonia drugs market in 2021. This is because of the rise in innovations in parenteral dosing and increased research and development for botulinum injections. Absorption of the medication, especially aqueous solutions, is rapid and uniform. There is a rapid commencement of effect compared to the oral and subcutaneous methods. Injection intramuscularly bypasses the drug's first-pass metabolism.

Distribution Channel Outlook

By distribution channel, the dystonia drugs market is classified into hospital pharmacies, online providers and drug stores & retail pharmacies. The drug stores & retail pharmacies segment witnessed the largest revenue share in the dystonia drugs market in 2021. This is due to its extensive chain of distribution networks and it being the oldest and most convenient channel for providing drugs to consumers. Retail pharmacists prepare and dispense drugs, counsel consumers on the proper use of medications, and inform them of potential drug interactions. Also, retail pharmacists advise clients regarding over-the-counter medications and general health concerns.

Regional Outlook

Region-wise, the dystonia drugs market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the dystonia drugs market in 2021. This is because of the growing occurrences of dystonia and the rise in the prevalence of other neurological disorders that cause dystonia in the population. In addition, the presence of a well-established healthcare infrastructure, a high purchasing power, and an increase in the diagnosis and treatment of dystonia in the region. The presence of a large number of unmet healthcare demands and a favorable regulatory environment are projected to boost the market's expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd., AbbVie, Inc., F. Hoffmann-La Roche Ltd., Ipsen Pharma Biotech SAS, Hameln Pharma Gmbh (Siegfried Group, LLP), Amneal Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, and Wellona Pharma.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Route of Administration

  • Oral
  • Injectable

By Type

  • GABAergic Agents
  • Dopaminergic Agents
  • Anticonvulsants Drugs
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Pfizer, Inc.
  • Novartis AG
  • Teva Pharmaceuticals Industries Ltd.
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ipsen Pharma Biotech SAS
  • Hameln Pharma Gmbh (Siegfried Group, LLP)
  • Amneal Pharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Wellona Pharma

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Dystonia Drugs Market, by Distribution Channel
    • 1.4.2 Global Dystonia Drugs Market, by Route of Administration
    • 1.4.3 Global Dystonia Drugs Market, by Type
    • 1.4.4 Global Dystonia Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Dystonia Drugs Market by Distribution Channel

  • 3.1 Global Drug Stores & Retail Pharmacies Market by Region
  • 3.2 Global Hospital Pharmacies Market by Region
  • 3.3 Global Online Providers Market by Region

Chapter 4. Global Dystonia Drugs Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Injectable Market by Region

Chapter 5. Global Dystonia Drugs Market by Type

  • 5.1 Global GABAergic Agents Market by Region
  • 5.2 Global Dopaminergic Agents Market by Region
  • 5.3 Global Anticonvulsants Drugs Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Dystonia Drugs Market by Region

  • 6.1 North America Dystonia Drugs Market
    • 6.1.1 North America Dystonia Drugs Market by Distribution Channel
      • 6.1.1.1 North America Drug Stores & Retail Pharmacies Market by Country
      • 6.1.1.2 North America Hospital Pharmacies Market by Country
      • 6.1.1.3 North America Online Providers Market by Country
    • 6.1.2 North America Dystonia Drugs Market by Route of Administration
      • 6.1.2.1 North America Oral Market by Country
      • 6.1.2.2 North America Injectable Market by Country
    • 6.1.3 North America Dystonia Drugs Market by Type
      • 6.1.3.1 North America GABAergic Agents Market by Country
      • 6.1.3.2 North America Dopaminergic Agents Market by Country
      • 6.1.3.3 North America Anticonvulsants Drugs Market by Country
      • 6.1.3.4 North America Others Market by Country
    • 6.1.4 North America Dystonia Drugs Market by Country
      • 6.1.4.1 US Dystonia Drugs Market
        • 6.1.4.1.1 US Dystonia Drugs Market by Distribution Channel
        • 6.1.4.1.2 US Dystonia Drugs Market by Route of Administration
        • 6.1.4.1.3 US Dystonia Drugs Market by Type
      • 6.1.4.2 Canada Dystonia Drugs Market
        • 6.1.4.2.1 Canada Dystonia Drugs Market by Distribution Channel
        • 6.1.4.2.2 Canada Dystonia Drugs Market by Route of Administration
        • 6.1.4.2.3 Canada Dystonia Drugs Market by Type
      • 6.1.4.3 Mexico Dystonia Drugs Market
        • 6.1.4.3.1 Mexico Dystonia Drugs Market by Distribution Channel
        • 6.1.4.3.2 Mexico Dystonia Drugs Market by Route of Administration
        • 6.1.4.3.3 Mexico Dystonia Drugs Market by Type
      • 6.1.4.4 Rest of North America Dystonia Drugs Market
        • 6.1.4.4.1 Rest of North America Dystonia Drugs Market by Distribution Channel
        • 6.1.4.4.2 Rest of North America Dystonia Drugs Market by Route of Administration
        • 6.1.4.4.3 Rest of North America Dystonia Drugs Market by Type
  • 6.2 Europe Dystonia Drugs Market
    • 6.2.1 Europe Dystonia Drugs Market by Distribution Channel
      • 6.2.1.1 Europe Drug Stores & Retail Pharmacies Market by Country
      • 6.2.1.2 Europe Hospital Pharmacies Market by Country
      • 6.2.1.3 Europe Online Providers Market by Country
    • 6.2.2 Europe Dystonia Drugs Market by Route of Administration
      • 6.2.2.1 Europe Oral Market by Country
      • 6.2.2.2 Europe Injectable Market by Country
    • 6.2.3 Europe Dystonia Drugs Market by Type
      • 6.2.3.1 Europe GABAergic Agents Market by Country
      • 6.2.3.2 Europe Dopaminergic Agents Market by Country
      • 6.2.3.3 Europe Anticonvulsants Drugs Market by Country
      • 6.2.3.4 Europe Others Market by Country
    • 6.2.4 Europe Dystonia Drugs Market by Country
      • 6.2.4.1 Germany Dystonia Drugs Market
        • 6.2.4.1.1 Germany Dystonia Drugs Market by Distribution Channel
        • 6.2.4.1.2 Germany Dystonia Drugs Market by Route of Administration
        • 6.2.4.1.3 Germany Dystonia Drugs Market by Type
      • 6.2.4.2 UK Dystonia Drugs Market
        • 6.2.4.2.1 UK Dystonia Drugs Market by Distribution Channel
        • 6.2.4.2.2 UK Dystonia Drugs Market by Route of Administration
        • 6.2.4.2.3 UK Dystonia Drugs Market by Type
      • 6.2.4.3 France Dystonia Drugs Market
        • 6.2.4.3.1 France Dystonia Drugs Market by Distribution Channel
        • 6.2.4.3.2 France Dystonia Drugs Market by Route of Administration
        • 6.2.4.3.3 France Dystonia Drugs Market by Type
      • 6.2.4.4 Russia Dystonia Drugs Market
        • 6.2.4.4.1 Russia Dystonia Drugs Market by Distribution Channel
        • 6.2.4.4.2 Russia Dystonia Drugs Market by Route of Administration
        • 6.2.4.4.3 Russia Dystonia Drugs Market by Type
      • 6.2.4.5 Spain Dystonia Drugs Market
        • 6.2.4.5.1 Spain Dystonia Drugs Market by Distribution Channel
        • 6.2.4.5.2 Spain Dystonia Drugs Market by Route of Administration
        • 6.2.4.5.3 Spain Dystonia Drugs Market by Type
      • 6.2.4.6 Italy Dystonia Drugs Market
        • 6.2.4.6.1 Italy Dystonia Drugs Market by Distribution Channel
        • 6.2.4.6.2 Italy Dystonia Drugs Market by Route of Administration
        • 6.2.4.6.3 Italy Dystonia Drugs Market by Type
      • 6.2.4.7 Rest of Europe Dystonia Drugs Market
        • 6.2.4.7.1 Rest of Europe Dystonia Drugs Market by Distribution Channel
        • 6.2.4.7.2 Rest of Europe Dystonia Drugs Market by Route of Administration
        • 6.2.4.7.3 Rest of Europe Dystonia Drugs Market by Type
  • 6.3 Asia Pacific Dystonia Drugs Market
    • 6.3.1 Asia Pacific Dystonia Drugs Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 6.3.1.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.1.3 Asia Pacific Online Providers Market by Country
    • 6.3.2 Asia Pacific Dystonia Drugs Market by Route of Administration
      • 6.3.2.1 Asia Pacific Oral Market by Country
      • 6.3.2.2 Asia Pacific Injectable Market by Country
    • 6.3.3 Asia Pacific Dystonia Drugs Market by Type
      • 6.3.3.1 Asia Pacific GABAergic Agents Market by Country
      • 6.3.3.2 Asia Pacific Dopaminergic Agents Market by Country
      • 6.3.3.3 Asia Pacific Anticonvulsants Drugs Market by Country
      • 6.3.3.4 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Dystonia Drugs Market by Country
      • 6.3.4.1 China Dystonia Drugs Market
        • 6.3.4.1.1 China Dystonia Drugs Market by Distribution Channel
        • 6.3.4.1.2 China Dystonia Drugs Market by Route of Administration
        • 6.3.4.1.3 China Dystonia Drugs Market by Type
      • 6.3.4.2 Japan Dystonia Drugs Market
        • 6.3.4.2.1 Japan Dystonia Drugs Market by Distribution Channel
        • 6.3.4.2.2 Japan Dystonia Drugs Market by Route of Administration
        • 6.3.4.2.3 Japan Dystonia Drugs Market by Type
      • 6.3.4.3 India Dystonia Drugs Market
        • 6.3.4.3.1 India Dystonia Drugs Market by Distribution Channel
        • 6.3.4.3.2 India Dystonia Drugs Market by Route of Administration
        • 6.3.4.3.3 India Dystonia Drugs Market by Type
      • 6.3.4.4 South Korea Dystonia Drugs Market
        • 6.3.4.4.1 South Korea Dystonia Drugs Market by Distribution Channel
        • 6.3.4.4.2 South Korea Dystonia Drugs Market by Route of Administration
        • 6.3.4.4.3 South Korea Dystonia Drugs Market by Type
      • 6.3.4.5 Singapore Dystonia Drugs Market
        • 6.3.4.5.1 Singapore Dystonia Drugs Market by Distribution Channel
        • 6.3.4.5.2 Singapore Dystonia Drugs Market by Route of Administration
        • 6.3.4.5.3 Singapore Dystonia Drugs Market by Type
      • 6.3.4.6 Malaysia Dystonia Drugs Market
        • 6.3.4.6.1 Malaysia Dystonia Drugs Market by Distribution Channel
        • 6.3.4.6.2 Malaysia Dystonia Drugs Market by Route of Administration
        • 6.3.4.6.3 Malaysia Dystonia Drugs Market by Type
      • 6.3.4.7 Rest of Asia Pacific Dystonia Drugs Market
        • 6.3.4.7.1 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel
        • 6.3.4.7.2 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration
        • 6.3.4.7.3 Rest of Asia Pacific Dystonia Drugs Market by Type
  • 6.4 LAMEA Dystonia Drugs Market
    • 6.4.1 LAMEA Dystonia Drugs Market by Distribution Channel
      • 6.4.1.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 6.4.1.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.1.3 LAMEA Online Providers Market by Country
    • 6.4.2 LAMEA Dystonia Drugs Market by Route of Administration
      • 6.4.2.1 LAMEA Oral Market by Country
      • 6.4.2.2 LAMEA Injectable Market by Country
    • 6.4.3 LAMEA Dystonia Drugs Market by Type
      • 6.4.3.1 LAMEA GABAergic Agents Market by Country
      • 6.4.3.2 LAMEA Dopaminergic Agents Market by Country
      • 6.4.3.3 LAMEA Anticonvulsants Drugs Market by Country
      • 6.4.3.4 LAMEA Others Market by Country
    • 6.4.4 LAMEA Dystonia Drugs Market by Country
      • 6.4.4.1 Brazil Dystonia Drugs Market
        • 6.4.4.1.1 Brazil Dystonia Drugs Market by Distribution Channel
        • 6.4.4.1.2 Brazil Dystonia Drugs Market by Route of Administration
        • 6.4.4.1.3 Brazil Dystonia Drugs Market by Type
      • 6.4.4.2 Argentina Dystonia Drugs Market
        • 6.4.4.2.1 Argentina Dystonia Drugs Market by Distribution Channel
        • 6.4.4.2.2 Argentina Dystonia Drugs Market by Route of Administration
        • 6.4.4.2.3 Argentina Dystonia Drugs Market by Type
      • 6.4.4.3 UAE Dystonia Drugs Market
        • 6.4.4.3.1 UAE Dystonia Drugs Market by Distribution Channel
        • 6.4.4.3.2 UAE Dystonia Drugs Market by Route of Administration
        • 6.4.4.3.3 UAE Dystonia Drugs Market by Type
      • 6.4.4.4 Saudi Arabia Dystonia Drugs Market
        • 6.4.4.4.1 Saudi Arabia Dystonia Drugs Market by Distribution Channel
        • 6.4.4.4.2 Saudi Arabia Dystonia Drugs Market by Route of Administration
        • 6.4.4.4.3 Saudi Arabia Dystonia Drugs Market by Type
      • 6.4.4.5 South Africa Dystonia Drugs Market
        • 6.4.4.5.1 South Africa Dystonia Drugs Market by Distribution Channel
        • 6.4.4.5.2 South Africa Dystonia Drugs Market by Route of Administration
        • 6.4.4.5.3 South Africa Dystonia Drugs Market by Type
      • 6.4.4.6 Nigeria Dystonia Drugs Market
        • 6.4.4.6.1 Nigeria Dystonia Drugs Market by Distribution Channel
        • 6.4.4.6.2 Nigeria Dystonia Drugs Market by Route of Administration
        • 6.4.4.6.3 Nigeria Dystonia Drugs Market by Type
      • 6.4.4.7 Rest of LAMEA Dystonia Drugs Market
        • 6.4.4.7.1 Rest of LAMEA Dystonia Drugs Market by Distribution Channel
        • 6.4.4.7.2 Rest of LAMEA Dystonia Drugs Market by Route of Administration
        • 6.4.4.7.3 Rest of LAMEA Dystonia Drugs Market by Type

Chapter 7. Company Profiles

  • 7.1 Pfizer, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional & Segmental Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Novartis AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
  • 7.3 Teva Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
  • 7.4 AbbVie, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 F. Hoffmann-La Roche Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Ipsen Pharma Biotech SAS
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Hameln Pharma Gmbh (Siegfried Group, LLP)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Research & Development Expenses
  • 7.8 Amneal Pharmaceuticals, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 Merz Pharma GmbH & Co. KGaA
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Approvals and Trials:
  • 7.10. Wellona Pharma
    • 7.10.1 Company Overview